Patients with gout: an under-recognised group at high risk of COVID-19.
作者信息
Dalbeth Nicola, Robinson Philip C
机构信息
Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland 1023, New Zealand.
University of Queensland Faculty of Medicine, Brisbane, QLD, Australia.
出版信息
Lancet Rheumatol. 2021 May;3(5):e317-e318. doi: 10.1016/S2665-9913(21)00073-4. Epub 2021 Mar 9.
Abstract
摘要
相似文献
1
Patients with gout: an under-recognised group at high risk of COVID-19.
Lancet Rheumatol. 2021 May;3(5):e317-e318. doi: 10.1016/S2665-9913(21)00073-4. Epub 2021 Mar 9.
2
A profile of health status and demographics of aged care facility residents with gout.
Australas J Ageing. 2020 Mar;39(1):e153-e161. doi: 10.1111/ajag.12716. Epub 2019 Aug 21.
3
High prevalence of gout in patients with Type 2 diabetes: male sex, renal impairment, and diuretic use are major risk factors.
N Z Med J. 2008 Oct 3;121(1283):43-50.
4
Gout in solid organ transplantation: a challenging clinical problem.
Drugs. 2005;65(18):2593-611. doi: 10.2165/00003495-200565180-00004.
5
Compliance in gout patients.
Acta Reumatol Port. 2010 Oct-Dec;35(5):466-74.
6
Gout in the writings of eminent ancient Greek and Byzantine physicians.
Acta Med Hist Adriat. 2011;9(1):83-8.
7
Gout: joints and beyond, epidemiology, clinical features, treatment and co-morbidities.
Maturitas. 2014 Aug;78(4):245-51. doi: 10.1016/j.maturitas.2014.05.001. Epub 2014 May 14.
8
[Analysis of serum ferritin and high sensitive C reactive protein in patients with gout].
Wei Sheng Yan Jiu. 2017 Mar;46(2):232-236.
9
Association Between Gout and Injury Risk: A National Retrospective Cohort Study.
Int J Environ Res Public Health. 2020 May 23;17(10):3679. doi: 10.3390/ijerph17103679.
10
Colchicine induced rhabdomyolysis.
Postgrad Med J. 2001 Mar;77(905):191-2. doi: 10.1136/pmj.77.905.191.
引用本文的文献
1
Community-engaged randomised controlled trial to disseminate COVID-19 vaccine-related information and increase uptake among Black individuals in two US cities with rheumatic conditions.
BMJ Open. 2024 Aug 24;14(8):e087918. doi: 10.1136/bmjopen-2024-087918.
2
Enrichment analysis and chromosomal distribution of gout susceptible loci identified by genome-wide association studies.
EXCLI J. 2023 Nov 14;22:1146-1154. doi: 10.17179/excli2023-6481. eCollection 2023.
3
Gout and Excess Risk of Severe SARS-CoV-2 Infection Among Vaccinated Individuals: A General Population Study.
Arthritis Rheumatol. 2023 Jan;75(1):122-132. doi: 10.1002/art.42339. Epub 2022 Nov 30.
4
Gout management and outcomes during established COVID-19 pandemic in 2020-2021: a cross-sectional Internet survey.
Ther Adv Musculoskelet Dis. 2022 May 13;14:1759720X221096381. doi: 10.1177/1759720X221096381. eCollection 2022.
5
Colchicine prophylaxis is associated with fewer gout flares after COVID-19 vaccination.
Ann Rheum Dis. 2022 Aug;81(8):1189-1193. doi: 10.1136/annrheumdis-2022-222199. Epub 2022 Mar 11.
6
Gout and the risk of COVID-19 diagnosis and death in the UK Biobank: a population-based study.
Lancet Rheumatol. 2022 Apr;4(4):e274-e281. doi: 10.1016/S2665-9913(21)00401-X. Epub 2022 Jan 28.
7
Women with gout and COVID-19-an unfortunate combination?
Lancet Rheumatol. 2022 Apr;4(4):e233-e234. doi: 10.1016/S2665-9913(22)00026-1. Epub 2022 Jan 28.
8
SARS-CoV-2 Infection and COVID-19 Outcomes in Rheumatic Diseases: A Systematic Literature Review and Meta-Analysis.
Arthritis Rheumatol. 2022 May;74(5):766-775. doi: 10.1002/art.42030. Epub 2022 Mar 28.
本文引用的文献
1
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry.
Ann Rheum Dis. 2021 Jul;80(7):930-942. doi: 10.1136/annrheumdis-2020-219498. Epub 2021 Jan 27.
2
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 3.
Arthritis Rheumatol. 2021 Feb;73(2):e1-e12. doi: 10.1002/art.41596. Epub 2020 Dec 5.
3
Gout management and outcomes during the COVID-19 pandemic: a cross-sectional internet survey.
Ther Adv Musculoskelet Dis. 2020 Oct 14;12:1759720X20966124. doi: 10.1177/1759720X20966124. eCollection 2020.
4
Variation in racial/ethnic disparities in COVID-19 mortality by age in the United States: A cross-sectional study.
PLoS Med. 2020 Oct 20;17(10):e1003402. doi: 10.1371/journal.pmed.1003402. eCollection 2020 Oct.
5
Factors associated with COVID-19-related death using OpenSAFELY.
Nature. 2020 Aug;584(7821):430-436. doi: 10.1038/s41586-020-2521-4. Epub 2020 Jul 8.
6
EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2.
Ann Rheum Dis. 2020 Jul;79(7):851-858. doi: 10.1136/annrheumdis-2020-217877. Epub 2020 Jun 5.
7
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study.
Lancet Rheumatol. 2020 Jun;2(6):e325-e331. doi: 10.1016/S2665-9913(20)30127-2. Epub 2020 May 7.
8
Care for patients with rheumatic diseases during COVID-19 pandemic: A position statement from APLAR.
Int J Rheum Dis. 2020 Jun;23(6):717-722. doi: 10.1111/1756-185X.13863. Epub 2020 May 27.
9
Cardiovascular disease risk factor assessment and management in gout: an analysis using guideline-based electronic clinical decision support.
N Z Med J. 2008 Nov 7;121(1285):73-81.
Zotero 插件